KZA
Click for more information
0.00% 8.0¢ kazia therapeutics limited

Ann: GBM Agile opens to paxalisib in Europe, page-13

  1. Rich&Poor
    1,148 Posts.
    lightbulb Created with Sketch. 819
    clock Created with Sketch.
    01/06/22
    21:13
    Post #: 61765373
    IMO, looking forward to being surprised by management with additional paxalisib regional GBM deals this year together with a FDA approval by the end of next year.
    EVT801 trial data presentations should also increase the future share value.

    Regards.



    KZA Price at posting: 79.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 7  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

TRP Tissue Repairs soars nearly 32% on TGA approval for wound healing gel
right-arrow Created with Sketch.
MM1 Geochemical work at Newington picks up gold and copper anomalies for Midas
right-arrow Created with Sketch.
PEC Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil
right-arrow Created with Sketch.
NEWS Real estate dynamics & changes raise investor doubt
right-arrow Created with Sketch.
BGL Bellevue aims for 45% production increase by FY 2028, announces $150M placement
right-arrow Created with Sketch.
NEWS Warren Tredrea’s weekly sports business wrap: the latest on business in sport
right-arrow Created with Sketch.
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.